secwatch.observer — SEC 8-K summary
======================================

Issuer:     QUEST DIAGNOSTICS INC (DGX)
CIK:        0001022079
Form:       8-K
Filed at:   2025-07-22T23:59:59+00:00
Accession:  0001022079-25-000172
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quest Diagnostics Q2 revenues $2.76B (+15.2%), beats; raises FY2025 adjusted EPS guidance to $9.63-$9.83
--------------------------------------------------------------------------------

- Q2 revenue $2.76B, up 15.2% YoY; organic revenue growth 5.2%.
- Reported diluted EPS $2.47 (+21.7%); adjusted diluted EPS $2.62 (+11.5%).
- Cash from operations $544M in Q2 (+51.5%); YTD $858M (+67.1%).
- Raises full-year 2025 net revenue guidance to $10.80B-$10.92B (from $10.70B-$10.85B).
- FY2025 adjusted diluted EPS guidance raised to $9.63-$9.83 from $9.55-$9.80.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022079/000102207925000172/0001022079-25-000172-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022079/000102207925000172/dgx-20250722.htm
  HTML page:      https://secwatch.observer/filing/0001022079-25-000172

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer